AI-based Clinical Trials Solution Providers Market Regional Analysis:
North American Market Insights
North America region is expected to account for more than 43% market share by 2035, owing to increasing penetration of AI-based tools and increasing government initiatives for adoption in different medical projects in the region. The region also has a rising corporate investment in artificial intelligence (AI) contributing market growth in the coming years. For instance, between 2018 and 2020, government agencies in the United States spent USD 1.9 billion on AI-related service obligations. Also, many ai-based startups opening their market in this region. For instance, BullFrog AI is a U.S. based ai startup, that creates bfLEAR an ai platform that allows precision medicines.
APAC Market Insights
Asia Pacific is also anticipated to hold the significant revenue shareby the end of 2035, owing to the increasing number of AI-based startups. The region also has an increasing awareness of AI-based clinical trials. Owing to the growing demand for AI tools and supportive government programs that focuses on the implementation of AI in the healthcare sector.
Europe Market Insights
Europe is anticipated to experience significant AI-based clinical trials solution providers market growth owing to the region's growing geriatric and target populations, expansion of key players' geographic markets, and active participation from governmental and nonprofit organizations.
